publication date: Nov. 14, 2014

Related Coverage of Lung Screening

 

CMS Inserts Unprecedented Conditions Into Medicare Coverage of Lung Screening

CT screening of the lungs of current and former heavy smokers is about to become a Medicare benefit.

A proposed decision published Nov. 10 has inserted some unprecedented conditions into its decision to cover screening:

Beneficiaries would have to go through counseling, and health professionals would be required to provide documentation that “shared decision-making” took place. The Centers for Medicare and Medicaid Services has never mandated shared decision-making as a gateway to paying for a service.

 

Groups Push For CMS Coverage For LDCT Lung Screening

A coalition of patient advocacy and medical organizations urged the Centers for Medicare & Medicaid Services to cover low-dose computed tomography for Medicare patients at high risk for lung cancer.

More than 60 organizations—including the American Society of Clinical Oncology, the American Cancer Society and several cancer centers—signed a 43-page joint letter to CMS recommending unrestricted national coverage for annual screening.

 

LDCT Proponents Lobby Congress To Push for Medicare Coverage

The Centers for Medicare and Medicaid Services have another six months to decide whether to cover low-dose computed tomography screening. Yet, proponents of screening seem unwilling to take the chance that Medicare coverage would be restrictive.

To tilt the scale in their favor, they have launched two congressional sign-on letters to CMS.

 

Steven Woolf: Why CMS Should Not Cover LDCT

National coverage for low-dose computed tomography may result in more harm than benefit to the Medicare population at this time, said Steven Woolf, a member of the Medicare Evidence Development & Coverage Advisory Committee.

Speaking at the April 30 MEDCAC hearing, Woolf said coverage would run into many implementation challenges and adherence problems—it would be unlikely that all practices would observe the strict criteria set by the U.S. Preventive Services Task Force and the National Lung Screening Trial, he said.

 

Bach: LCA Center Certification Untrustworthy; CISNET Models Don’t Match

When it appeared that CT screening for lung cancer was a shoo-in for Medicare coverage, the Lung Cancer Alliance, an advocacy group, started to certify “screening centers of excellence.”

Centers all over the country received this designation from LCA and were listed on the group’s website.

However, as he prepared for a recent Medicare advisory committee meeting, Peter Bach, a pulmonologist and health systems researcher at the Memorial Sloan-Kettering Cancer Center, checked the list of LCA-certified centers.

 

CMS Advisors Express Low Confidence In Low-Dose CT Screening for Lung Cancer

An advisory panel for the Centers for Medicare and Medicaid Services expressed low confidence in low-dose computed tomography as a method for screening for lung cancer in the Medicare population.

Evidence is inadequate to ensure that benefits of the procedure would outweigh harms, the Medicare Evidence Development & Coverage Advisory Committee said at the hearing April 30.

 

In a Change of Heart, LCA Endorses NLST

Almost one decade ago, Laurie Fenton-Ambrose, president and CEO of the Lung Cancer Alliance, described the National Lung Screening Trial as “failed” and “outdated.”

At that time, LCA spearheaded an effort to launch a congressional probe of the NLST investigators.

 

Kazerooni: The Case for Broad Coverage

The Cancer Letter asked Ella Kazerooni, a professor of radiology at the University of Michigan, chair of the American College of Radiology Committee on Lung Screening, and vice chair of the lung screening panel of the National Comprehensive Cancer Network, to lay out the rationale for a proposal for broad coverage for lung screening. 

Does a B from USPSTF Guarantee Coverage? Lung Screening will Define Medicare Stance

The Centers for Medicare and Medicaid Services is facing the formidable challenge of deciding what kinds of patients should be screened for lung cancer.

The agency’s Medicare Evidence Development & Coverage Advisory Committee will meet April 30 to decide how the positive findings of a large randomized trial and the recommendation the U.S. Preventive Services Task Force should be translated into policy.

Task Force Issues Guideline on LDCT Lung Screening

The U.S. Preventive Services Task Force released its final recommendation statement on screening for lung cancer with low-dose computed tomography.

Annual LDCT screening can reduce lung cancer mortality of high-risk persons aged 55 to 80 years who have a 30 pack-year smoking history and currently smoke, or have quit within the past 15 years, the 16-member task force determined.

 

What? Only a “B”? NLST Co-Principal Investigator Begs to Differ with USPSTF Lung Cancer Screening Grade

 

With a “B” from USPSTF, Low-dose CT Screening For Lung Cancer Earns Coverage Under ACA

 

Lung Screening Advocates Say Verdict’s In, Attack NCI Randomized Trial As “Outdated.”

 

NEJM Says Henschke Conflicts Irrelevant; Propriety Of Granting CME Questioned

 

Tobacco Company Liggett Gave $3.6 Million To Henschke For CT Screening Research

 

NEJM Sanctioned For Giving CME Credit For Controversial Lung Screening Paper; ACCME Demanded Corrective Action

 

NLST Shows 20.3 Percent Mortality Benefit For CT Vs. X-Ray In Lung Cancer Screening

Copyright (c) 2020 The Cancer Letter Inc.